Schedule 13G ownership disclosure

Coherus Oncology Inc

Common Stock, $0.0001 par value per share · CUSIP: 19249H103

Event date: 2025-04-14

Filing-level shares
6,009,514.00
Percent of class
5.2%
  • Thomas A. Satterfield, Jr.

    Shares: 6,009,514.00 · Class: 5.2%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-035581
Form type
SCHEDULE 13G
Filer
Coherus Oncology, Inc.
CIK
CIK 1512762
Filed
Apr 16, 2025
Reporting period
Apr 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub